# DUSA Pharmaceuticals, Inc., Billerica, MA – FDA Inspections

Source: https://www.keypedia.com/companies/dusa-pharmaceuticals-inc/477fe89d-b607-4aae-82b5-23a02cca9bd0

> Inspection records and compliance data for DUSA Pharmaceuticals, Inc. in Billerica, Massachusetts. 7 FDA inspections on record, 1 Form 483, last inspected September 08, 2023.

---

## Details

- Name: DUSA Pharmaceuticals, Inc.
- FEI Number: 3002513708
- Address Line 1: 29 Dunham Rd
- City: Billerica
- State: Massachusetts
- Zip Code: 01821
- Country Name: United States
- Address: 29 Dunham Rd, Billerica, Massachusetts 01821, United States
- Country: United States

## Related Documents

- [483 - DUSA Pharmaceuticals, Inc. - 2023-09-08](https://www.keypedia.com/records/483/dusa-pharmaceuticals-inc/c15d773c-ef91-4e81-8cb9-ba680ced2f52) — source: FDA, date: September 8, 2023
- [483 - DUSA Pharmaceuticals, Inc. - 2023-09-08](https://www.keypedia.com/records/483/dusa-pharmaceuticals-inc/7f3d4fc5-45bd-43e9-b124-6aa84d7edb50) — source: FDA, date: September 8, 2023
- [FDA Inspection 1217179 - DUSA Pharmaceuticals, Inc. - 2023-09-08](https://www.keypedia.com/records/fda_inspections/dusa-pharmaceuticals-inc/473e61bf-5426-48c4-a8a0-9785e8266127) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 8, 2023
- FDA Inspection 986674 - DUSA Pharmaceuticals, Inc. - 2016-09-22 — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2016
- FDA Inspection 986674 - DUSA Pharmaceuticals, Inc. - 2016-09-22 — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2016
- FDA Inspection 986674 - DUSA Pharmaceuticals, Inc. - 2016-09-22 — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2016
- FDA Inspection 986674 - DUSA Pharmaceuticals, Inc. - 2016-09-22 — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2016
- FDA Inspection 934706 - DUSA Pharmaceuticals, Inc. - 2015-05-29 — classification: No Action Indicated (NAI), source: FDA, date: May 29, 2015
- FDA Inspection 934706 - DUSA Pharmaceuticals, Inc. - 2015-05-29 — classification: No Action Indicated (NAI), source: FDA, date: May 29, 2015
- [FDA Inspection 788414 - DUSA Pharmaceuticals, Inc. - 2012-06-20](https://www.keypedia.com/records/fda_inspections/dusa-pharmaceuticals-inc/7c7cb1ec-2fb2-43a7-af20-0e7060e3d401) — classification: No Action Indicated (NAI), source: FDA, date: June 20, 2012
- FDA Inspection 788414 - DUSA Pharmaceuticals, Inc. - 2012-06-20 — classification: No Action Indicated (NAI), source: FDA, date: June 20, 2012
- FDA Inspection 777605 - DUSA Pharmaceuticals, Inc. - 2012-04-18 — classification: No Action Indicated (NAI), source: FDA, date: April 18, 2012

## Related Companies

- [Ortec](https://www.keypedia.com/companies/ortec/e7a88df3-0ce8-4995-83ef-628dbc45bd8f)
- [Spaulding Medical LLC](https://www.keypedia.com/companies/spaulding-medical-llc/7ac7fe7b-ab8d-41fd-91d5-7c25204c736d)
- [University of North Texas Health Science Center-IRB](https://www.keypedia.com/companies/university-of-north-texas-health-science-center-irb/f587e370-1903-4150-b994-4f11bd54dd27)
- [Medisca Inc](https://www.keypedia.com/companies/medisca-inc/7448a6fa-f3ce-459e-aaed-4449c225f9c4)
- [Discus Dental LLC](https://www.keypedia.com/companies/discus-dental-llc/57f068c1-0e7a-4e0f-ade3-bab358a78848)
- [Septodont Inc.](https://www.keypedia.com/companies/septodont-inc/eb4216fd-e7d3-4b75-b488-681239e138aa)
- [Biomedical Systems Corp](https://www.keypedia.com/companies/biomedical-systems-corp/99dc0494-ee3b-451b-bdfb-21e50304e436)
- [Amita Health IRB](https://www.keypedia.com/companies/amita-health-irb/aa991a53-c6f8-44e1-9d0a-60fff2331981)
- [Sciarra Laboratories, Inc.](https://www.keypedia.com/companies/sciarra-laboratories-inc/524d2f58-5717-46af-bdb2-7289f54a823d)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/99f38647-05a1-47b9-8628-66fe0bedb146)

## Related Officers

- [Sunita Pandey](https://www.keypedia.com/people/sunita-pandey/008e5bb8-0eb3-45d8-8524-734ac0454250)